DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIDOCAINE; TETRACAINE

« Back to Dashboard

Clinical Trials for Lidocaine; Tetracaine

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00107822	Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children	Completed	ZARS Pharma Inc.	Phase 3	The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in children. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.
NCT00107835	Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults	Completed	ZARS Pharma Inc.	Phase 3	The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in adults. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.
NCT00110253	Duration of Skin Numbing Effect Created by the S-Caine™ Peel	Completed	ZARS Pharma Inc.	Phase 3	S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a new skin numbing cream made of lidocaine and tetracaine. The purpose of this study is to evaluate and measure the length of time the S-Caine Peel numbs the skin, when applied for 30 and 60 minutes.
NCT00110734	S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults	Completed	ZARS Pharma Inc.	Phase 3	There is pain associated with laser-assisted tattoo removal. For this reason, some form of anesthesia is commonly used to eliminate or minimize the pain. This anesthesia is usually a topical local anesthetic cream or ointment spread over the skin. The purpose of this study is to further estimate the effectiveness of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) for treating pain during laser-assisted tattoo removal.

Clinical Trial Conditions for Lidocaine; Tetracaine

Condition Name

Condition Name for Lidocaine; Tetracaine
Intervention	Trials
Pain	15
Healthy	3
Acne Scars - Mixed Atrophic and Hypertrophic	1
Retinal Vein Occlusion	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lidocaine; Tetracaine
Intervention	Trials
Macular Degeneration	3
Retinal Vein Occlusion	2
Syndrome	2
Macular Edema	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lidocaine; Tetracaine

Trials by Country

Trials by Country for Lidocaine; Tetracaine
Location	Trials
United States	44
Canada	4
Italy	3
Saudi Arabia	2
Netherlands	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lidocaine; Tetracaine
Location	Trials
Texas	6
Florida	5
New York	5
Michigan	4
Tennessee	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lidocaine; Tetracaine

Clinical Trial Phase

Clinical Trial Phase for Lidocaine; Tetracaine
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	9
Phase 2	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lidocaine; Tetracaine
Clinical Trial Phase	Trials
Completed	31
Unknown status	6
Not yet recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lidocaine; Tetracaine

Sponsor Name

Sponsor Name for Lidocaine; Tetracaine
Sponsor	Trials
ZARS Pharma Inc.	16
Lawson Health Research Institute	2
The University of Texas Health Science Center, Houston	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lidocaine; Tetracaine
Sponsor	Trials
Other	31
Industry	19

Export unavailable in trial.
Subscribe for complete access.